DDrare: Database of Drug Development for Rare Diseases

47. バージャー病
［臨床試験数：7，薬物数：9（DrugBank：4），標的遺伝子数：4，標的パスウェイ数：13］

Searched query = "Buerger disease", "Thromboangiitis obliterans"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Allogeneic Mesenchymal Stem Cells; Bosentan; CLBS12; Erythropoietin; G-CSF; RNL-Vascostem®; SOC; Stempeucel(R); Thrombopoietin

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000005227	2011/03/01	09/03/2011	Transplantation of autologous and G-CSF mobilized mononuclear cells in patients with critical limb ischemia (CLI)		CLI (Atherosclerotic PAD/Buerger disease )	Subcutaneous administration of G-CSF, Harvest and implantation of PB-MNC	Regenerative Medicine Unit, Division of Vascular Regeneration Therapy, Institute of Biomedical Research and Innovation (IBRI)	NULL	Complete: follow-up complete	20years-old	80years-old	Male and Female	5	Not selected	Japan

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

JPRN-UMIN000005227

2011/03/01

09/03/2011

Transplantation of autologous and G-CSF mobilized mononuclear cells in patients with critical limb ischemia (CLI)

CLI (Atherosclerotic PAD/Buerger disease )

Subcutaneous administration of G-CSF, Harvest and implantation of PB-MNC

Regenerative Medicine Unit, Division of Vascular Regeneration Therapy, Institute of Biomedical Research and Innovation (IBRI)

NULL

Complete: follow-up complete

20years-old

80years-old

Male and Female

Not selected

Japan